GSE	org	CellType	Treat	CancerType	CID	Category	Target	NotesGSE110397	hsa	8988T	Palbociclib	PAAD	5330286	Targeted therapy	CDK4/6	KinaseGSE110397	hsa	8988T	Trametinib	PAAD	11707110	Targeted therapy	MEK	KinaseGSE110397	hsa	8988T	Palbociclib+Trametinib	PAAD		CombinationGSE98230	hsa	A2780	5-FdU-ECyd	OV		Chemotherapy	conjugated antimetaboliteGSE98230	hsa	A2780R	5-FdU-ECyd	OV		Chemotherapy	conjugated antimetaboliteGSE59340	hsa	A375	Crizotinib	SKCM	11626560	Targeted therapy	ALK	TKIGSE35230	hsa	A375	GSK436	SKCM	44462760	Targeted therapy	BRAF	OncogeneGSE68453	hsa	A375	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE89127	hsa	A375	Vemurafenib	SKCM	42611257	Targeted therapy	BRAF	OncogeneGSE89127	hsa	A375	THZ1	SKCM	73602827	Targeted therapy	CDK7	KinaseGSE68453	hsa	A375	Mastinib	SKCM	10074640	Targeted therapy	cKit/PDGFR/Lck/FAK/FGFR3	TKIGSE68453	hsa	A375	Lapatinib	SKCM	208908	Targeted therapy	HER2/neu & EGFR	TKIGSE35230	hsa	A375	GSK212	SKCM	11707110	Targeted therapy	MEK1/2	KinaseGSE68453	hsa	A375	PLX4720+Lapatinib	SKCM		CombinationGSE68453	hsa	A375	PLX4720+Mastinib	SKCM		CombinationGSE89127	hsa	A375	Vemurafenib+THZ1	SKCM		CombinationGSE59183	hsa	A375	Lactimidomycin	SKCM	11669726	Chemotherapy	inhibitor of protein translation in ribosomesGSE59340	hsa	A375	Ciclopirox	SKCM	2749	Chemotherapy	Protein SynthesisGSE59183	hsa	A375	Trifluridine	SKCM	6256	ChemotherapyGSE69742	hsa	A375 xenograft	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE69742	hsa	A375 xenograft	Bevacizumab	SKCM	135329020	Targeted therapy	VEGFA	OthersGSE69742	hsa	A375 xenograft	PLX4720+Bevacizumab	SKCM		CombinationGSE35230	hsa	A375.R	GSK436	SKCM	44462760	Targeted therapy	BRAF	OncogeneGSE35230	hsa	A375.R	GSK212	SKCM	11707110	Targeted therapy	MEK1/2	KinaseGSE102639	hsa	A549	AZD1132	LUAD	11497983	Targeted therapy	AURKB	KinaseGSE102639	hsa	A549	MLN8237	LUAD	24771867	Targeted therapy	AURKB	KinaseGSE102639	hsa	A549	VX680	LUAD	5494449	Targeted therapy	AURKB	KinaseGSE110397	hsa	A549	Palbociclib	LUAD	5330286	Targeted therapy	CDK4/6	KinaseGSE89127	hsa	A549	THZ1	LUAD	73602827	Targeted therapy	CDK7	KinaseGSE57422	hsa	A549	Erlotinib	LUAD	176870	Targeted therapy	EGFR	TKIGSE110397	hsa	A549	Trametinib	LUAD	11707110	Targeted therapy	MEK	KinaseGSE89127	hsa	A549	GSK1120212	LUAD	11707110	Targeted therapy	MEK	KinaseGSE63593	hsa	A549	PS432	LUAD		Targeted therapy	PKC	KinaseGSE63593	hsa	A549	PSX146	LUAD		Targeted therapy	PKC	KinaseGSE63593	hsa	A549	PSX626	LUAD		Targeted therapy	PKC	KinaseGSE63593	hsa	A549	PSX706	LUAD		Targeted therapy	PKC	KinaseGSE57422	hsa	A549	Quinacrine	LUAD	237	OthersGSE110397	hsa	A549	Palbociclib+Trametinib	LUAD		CombinationGSE89127	hsa	A549	GSK1120212+THZ1	LUAD		CombinationGSE102639	hsa	A549	Etoposide	LUAD	36462	Chemotherapy	TOP2B,TOP2AGSE111305	hsa	Adipocyte	Guadecitabine	OV	135564655	Targeted therapy	DNMT	EpigeneticGSE73024	hsa	AN3CA	CH5183284	UCEC	66555680	Targeted therapy	FGFR	TKIGSE74514	hsa	B-CLL	2cPE	B lymphoma		Targeted therapy	Isopeptidase	OthersGSE74514	hsa	B-CLL	Bortezomib	B lymphoma	387447	Targeted therapy	proteasome	OthersGSE40837	hsa	BRCA	Sorafenib	BRCA	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE39693	hsa	BreastTumor	Everolimus	BRCA	6442177	Targeted therapy	mTOR	KinaseGSE41816	hsa	BT549	AZD6244	BRCA	10127622	Targeted therapy	MEK1/2	KinaseGSE41816	hsa	BT549	siDUSP4	BRCA		Single gene perturbation	DUSP4GSE81363	hsa	BxPC3	Deferasirox	PAAD	214348	Chemotherapy	iron chelating agentGSE45891	hsa	Cal27	Erlotinib	Oral cancer	176870	Targeted therapy	EGFR	TKIGSE50791	hsa	Colo205	PLX4720	COAD_READ	24180719	Targeted therapy	BRAF	OncogeneGSE15781	hsa	CRC.Normal	Radiochemotherapy	COAD_READ		ChemotherapyGSE15781	hsa	CRC.Patient	Radiochemotherapy	COAD_READ		ChemotherapyGSE43510	hsa	DHL4	R406	DLBCL	11984591	Targeted therapy	SYK	TKIGSE43510	hsa	DHL6	R406	DLBCL	11984591	Targeted therapy	SYK	TKIGSE68453	hsa	DM122	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	DM13	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	DM331	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	DM331	Mastinib	SKCM	10074640	Targeted therapy	cKit/PDGFR/Lck/FAK/FGFR3	TKIGSE68453	hsa	DM331	Lapatinib	SKCM	208908	Targeted therapy	HER2/neu & EGFR	TKIGSE68453	hsa	DM331	PLX4720+Lapatinib	SKCM		CombinationGSE68453	hsa	DM331	PLX4720+Mastinib	SKCM		CombinationGSE68453	hsa	DM6	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE73024	hsa	DMS-114	CH5183284	LUAD	66555680	Targeted therapy	FGFR	TKIGSE38310	hsa	ER3	Erlotinib	LUAD	176870	Targeted therapy	EGFR	TKIGSE67529	hsa	EW5.PDX	mTORi	SARC		Targeted therapy	mTOR	KinaseGSE67529	hsa	EW5.PDX	IGF-1Ri	SARC		Single gene perturbation	IGF-1RGSE45891	hsa	FADU	Erlotinib	HNSCC	176870	Targeted therapy	EGFR	TKIGSE79316	hsa	Glioma	BEZ235	GBM	11977753	Targeted therapy	PI3K/mTOR	KinaseGSE79316	hsa	Glioma	DS7423	GBM		Targeted therapy	PI3K/mTOR	KinaseGSE96760	hsa	H-STS	BIO	Neuroendocrine tumor		UnknownGSE96760	hsa	H-STS	Istradefylline	Neuroendocrine tumor	5311037	Targeted therapy	A2A receptor	OthersGSE96760	hsa	H-STS	Alisertib	Neuroendocrine tumor	24771867	Targeted therapy	AURKA	KinaseGSE96760	hsa	H-STS	PAC-1	Neuroendocrine tumor	135421197	Targeted therapy	activating procaspase-3	OthersGSE96760	hsa	H-STS	SCH-529074	Neuroendocrine tumor	12001922	Targeted therapy	activator of mutant p53	OthersGSE96760	hsa	H-STS	MK-2206	Neuroendocrine tumor	24964624	Targeted therapy	AKT	KinaseGSE96760	hsa	H-STS	Crizotinib	Neuroendocrine tumor	11626560	Targeted therapy	ALK	TKIGSE96760	hsa	H-STS	LDK378	Neuroendocrine tumor	57379345	Targeted therapy	ALK	TKIGSE96760	hsa	H-STS	DBeQ	Neuroendocrine tumor	676352	Targeted therapy	ATPase p97	OthersGSE96760	hsa	H-STS	Obatoclax	Neuroendocrine tumor	16681698	Targeted therapy	Bcl-2	OncogeneGSE96760	hsa	H-STS	TW-37	Neuroendocrine tumor	11455910	Targeted therapy	Bcl-2	OncogeneGSE96760	hsa	H-STS	Dasatinib	Neuroendocrine tumor	3062316	Targeted therapy	Bcr-Abl	TKIGSE96760	hsa	H-STS	Imatinib	Neuroendocrine tumor	5291	Targeted therapy	Bcr-Abl	TKIGSE96760	hsa	H-STS	NIlotinib	Neuroendocrine tumor	644241	Targeted therapy	Bcr-Abl	TKIGSE96760	hsa	H-STS	GSK1210151A	Neuroendocrine tumor	52912189	Targeted therapy	BRD	EpigeneticGSE96760	hsa	H-STS	Ibrutinib	Neuroendocrine tumor	24821094	Targeted therapy	BTK	TKIGSE96760	hsa	H-STS	LEE011	Neuroendocrine tumor	44631912	Targeted therapy	CDK4/6	KinaseGSE96760	hsa	H-STS	Flavopiridol	Neuroendocrine tumor	5287969	Targeted therapy	CDK9	KinaseGSE96760	hsa	H-STS	Dinaciclib	Neuroendocrine tumor	46926350	Targeted therapy	CDKs	KinaseGSE96760	hsa	H-STS	NVP-231	Neuroendocrine tumor	90570	Targeted therapy	CERK	KinaseGSE96760	hsa	H-STS	AZD7762	Neuroendocrine tumor	11152667	Targeted therapy	CHK	KinaseGSE96760	hsa	H-STS	INC280	Neuroendocrine tumor		Targeted therapy	cMET	TKIGSE96760	hsa	H-STS	PHA-665752	Neuroendocrine tumor	10461815	Targeted therapy	cMET	TKIGSE96760	hsa	H-STS	SU11274	Neuroendocrine tumor	9549297	Targeted therapy	cMET	TKIGSE96760	hsa	H-STS	Tivantinib	Neuroendocrine tumor	11494412	Targeted therapy	cMET	TKIGSE96760	hsa	H-STS	Foretinib	Neuroendocrine tumor	42642645	Targeted therapy	cMET/VEGFR	TKIGSE96760	hsa	H-STS	Leptomycin B in Ethanol	Neuroendocrine tumor		Targeted therapy	CRM1	OthersGSE96760	hsa	H-STS	SB-225002	Neuroendocrine tumor	3854666	Targeted therapy	CXCR2 antagonists	OthersGSE96760	hsa	H-STS	Afatinib	Neuroendocrine tumor	10184653	Targeted therapy	EGFR	TKIGSE96760	hsa	H-STS	LY-2183240	Neuroendocrine tumor	11507802	Targeted therapy	FAAH	EpigeneticGSE96760	hsa	H-STS	PF-573228	Neuroendocrine tumor	11612883	Targeted therapy	FAK	EpigeneticGSE96760	hsa	H-STS	BGJ398	Neuroendocrine tumor	53235510	Targeted therapy	FGFRs	TKIGSE96760	hsa	H-STS	KW 2449	Neuroendocrine tumor	11427553	Targeted therapy	FLT3, ABL, ABL-T315I, and Aurora kinase	TKIGSE96760	hsa	H-STS	ML210	Neuroendocrine tumor		Targeted therapy	GPX4	OthersGSE96760	hsa	H-STS	Belinostat	Neuroendocrine tumor	6918638	Targeted therapy	HDAC	EpigeneticGSE96760	hsa	H-STS	Entinostat	Neuroendocrine tumor	4261	Targeted therapy	HDAC	EpigeneticGSE96760	hsa	H-STS	Panobinostat	Neuroendocrine tumor	6918837	Targeted therapy	HDAC	EpigeneticGSE96760	hsa	H-STS	Vorinostat	Neuroendocrine tumor	5311	Targeted therapy	HDACI/II/IV	EpigeneticGSE96760	hsa	H-STS	Neratinib	Neuroendocrine tumor	9915743	Targeted therapy	HER-2	TKIGSE96760	hsa	H-STS	Fluvastatin	Neuroendocrine tumor	446155	Targeted therapy	HMG-CoA	OthersGSE96760	hsa	H-STS	At13387	Neuroendocrine tumor	11955716	Targeted therapy	Hsp90	OthersGSE96760	hsa	H-STS	AUY922	Neuroendocrine tumor	135539077	Targeted therapy	Hsp90	OthersGSE96760	hsa	H-STS	SNX-2112	Neuroendocrine tumor	24772860	Targeted therapy	Hsp90	OthersGSE96760	hsa	H-STS	BMS-754807	Neuroendocrine tumor	24785538	Targeted therapy	IGF-IR/InsR	TKIGSE96760	hsa	H-STS	Manumycin A	Neuroendocrine tumor	6438330	Targeted therapy	IKK	OthersGSE96760	hsa	H-STS	Methylstat	Neuroendocrine tumor	53392493	Targeted therapy	JHDMs	EpigeneticGSE96760	hsa	H-STS	SB-743921	Neuroendocrine tumor	49867937	Targeted therapy	KSP	OthersGSE96760	hsa	H-STS	Bafetinib	Neuroendocrine tumor	11387605	Targeted therapy	Lyn/Bcr-Abl	TKIGSE96760	hsa	H-STS	Nutlin-3	Neuroendocrine tumor	216345	Targeted therapy	MDM2	OncogeneGSE96760	hsa	H-STS	Necrosulfonamide	Neuroendocrine tumor	1566236	Targeted therapy	MLKL	KinaseGSE96760	hsa	H-STS	KU-0063794	Neuroendocrine tumor	16736978	Targeted therapy	mTOR	KinaseGSE96760	hsa	H-STS	RAD001	Neuroendocrine tumor	6442177	Targeted therapy	mTOR	KinaseGSE96760	hsa	H-STS	AZD8055	Neuroendocrine tumor	25262965	Targeted therapy	mTORC1/2	KinaseGSE96760	hsa	H-STS	CAY10618	Neuroendocrine tumor	44819697	Targeted therapy	NMPRTase	OthersGSE96760	hsa	H-STS	FK866	Neuroendocrine tumor		Targeted therapy	NMPRTase	OthersGSE96760	hsa	H-STS	JNJ-26854165	Neuroendocrine tumor	11609586	Targeted therapy	p53 activator	OthersGSE96760	hsa	H-STS	PF-3758309	Neuroendocrine tumor	25227462	Targeted therapy	PAK4	KinaseGSE96760	hsa	H-STS	SCH-79797	Neuroendocrine tumor	4259181	Targeted therapy	PAR1	OthersGSE96760	hsa	H-STS	AZD6482	Neuroendocrine tumor	44137675	Targeted therapy	PI3K	KinaseGSE96760	hsa	H-STS	BKM120	Neuroendocrine tumor	16654980	Targeted therapy	PI3K	KinaseGSE96760	hsa	H-STS	BYL719	Neuroendocrine tumor	56649450	Targeted therapy	PI3K	KinaseGSE96760	hsa	H-STS	GDC-0941	Neuroendocrine tumor	17755052	Targeted therapy	PI3K	KinaseGSE96760	hsa	H-STS	PKC412	Neuroendocrine tumor		Targeted therapy	PKC	KinaseGSE96760	hsa	H-STS	BI-2536	Neuroendocrine tumor	11364421	Targeted therapy	PLK	KinaseGSE96760	hsa	H-STS	GSK461364	Neuroendocrine tumor	15983966	Targeted therapy	PLK	KinaseGSE96760	hsa	H-STS	HMN	Neuroendocrine tumor	445522	Targeted therapy	PLK	KinaseGSE96760	hsa	H-STS	Bortezomib	Neuroendocrine tumor	387447	Targeted therapy	proteasome	OthersGSE96760	hsa	H-STS	MG-132	Neuroendocrine tumor	462382	Targeted therapy	proteasome	OthersGSE96760	hsa	H-STS	Rigosertib	Neuroendocrine tumor	6918736	Targeted therapy	RAS	OncogeneGSE96760	hsa	H-STS	Pluripotin	Neuroendocrine tumor	12003241	Targeted therapy	RasGAP	OthersGSE96760	hsa	H-STS	Y-27632	Neuroendocrine tumor	448042	Targeted therapy	ROCK	KinaseGSE96760	hsa	H-STS	Bexarotene	Neuroendocrine tumor	82146	Targeted therapy	RXRs	OthersGSE96760	hsa	H-STS	KX2-391	Neuroendocrine tumor	23635314	Targeted therapy	Src	TKIGSE96760	hsa	H-STS	YM-155	Neuroendocrine tumor	11178236	Targeted therapy	Survinin	OthersGSE96760	hsa	H-STS	(5Z)-7-Oxozeanol	Neuroendocrine tumor		Targeted therapy	TAK1	KinaseGSE96760	hsa	H-STS	MST-312	Neuroendocrine tumor	10385095	Targeted therapy	Telomerase	OthersGSE96760	hsa	H-STS	Piperlongumine	Neuroendocrine tumor	637858	Targeted therapy	TrxR1	OthersGSE96760	hsa	H-STS	CHM-1	Neuroendocrine tumor	375860	Targeted therapy	Vascular Targeting Agent (inducing apoptosis)	OthersGSE96760	hsa	H-STS	Erastin	Neuroendocrine tumor	11214940	Targeted therapy	VDAC2,VDAC3	OthersGSE96760	hsa	H-STS	Linifanib	Neuroendocrine tumor	11485656	Targeted therapy	VEGF/PDGF	OthersGSE96760	hsa	H-STS	Brivanib	Neuroendocrine tumor	11234052	Targeted therapy	VEGFR-2	TKIGSE96760	hsa	H-STS	Sunitinib	Neuroendocrine tumor	5329102	Targeted therapy	VEGFR, PDGFR	TKIGSE96760	hsa	H-STS	Sorafenib	Neuroendocrine tumor	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE96760	hsa	H-STS	MK-1775	Neuroendocrine tumor	24856436	Targeted therapy	WEE1	TKIGSE96760	hsa	H-STS	Rosiglitazone	Neuroendocrine tumor	77999	Others	an agonist for PPAR GAMMA.GSE96760	hsa	H-STS	Ethanol	Neuroendocrine tumor	702	Others	bactericidalGSE96760	hsa	H-STS	GW-405833	Neuroendocrine tumor	9911463	Others	Cannabinoid CB2 AgonistGSE96760	hsa	H-STS	KHS101	Neuroendocrine tumor		Others	disrupt energy metabolismGSE96760	hsa	H-STS	Cerulenin	Neuroendocrine tumor	5282054	Others	FASNGSE96760	hsa	H-STS	CD-437	Neuroendocrine tumor	135411	Others	RARGSE96760	hsa	H-STS	Fingolimod	Neuroendocrine tumor	107970	Others	Sphingosine 1-phosphate Receptor ModulatorGSE96760	hsa	H-STS	Arachidonyl	Neuroendocrine tumor		OthersGSE96760	hsa	H-STS	Bardoxolone methyl	Neuroendocrine tumor	400769	OthersGSE96760	hsa	H-STS	Epigallocatechin gallate	Neuroendocrine tumor	65064	OthersGSE96760	hsa	H-STS	Methanol	Neuroendocrine tumor	887	OthersGSE96760	hsa	H-STS	Parbendazole	Neuroendocrine tumor	26596	OthersGSE96760	hsa	H-STS	Parthenolide	Neuroendocrine tumor	7251185	OthersGSE96760	hsa	H-STS	Brefeldin A	Neuroendocrine tumor	5287620	Chemotherapy	AutophagyGSE96760	hsa	H-STS	Vincristine	Neuroendocrine tumor	5978	Chemotherapy	binds irreversibly to microtubules and spindle proteins in S phase of the cell cycleGSE96760	hsa	H-STS	Docetaxel	Neuroendocrine tumor	148124	Chemotherapy	disrupting the normal function of microtubulesGSE96760	hsa	H-STS	YK-4-279	Neuroendocrine tumor	44632017	Chemotherapy	ETV1GSE96760	hsa	H-STS	Gossypol	Neuroendocrine tumor	3503	Chemotherapy	induces cell cycle arrest at the G0/G1 phaseGSE96760	hsa	H-STS	Mitomycin C	Neuroendocrine tumor	5746	Chemotherapy	inhibition of DNA synthesiGSE96760	hsa	H-STS	Paclitaxel	Neuroendocrine tumor	36314	Chemotherapy	MicrotubuleGSE96760	hsa	H-STS	Gemcitabine	Neuroendocrine tumor	60750	Chemotherapy	Nucleic Acid Synthesis inhibitorGSE96760	hsa	H-STS	Ciclopirox	Neuroendocrine tumor	2749	Chemotherapy	Protein SynthesisGSE96760	hsa	H-STS	Mithramycin A	Neuroendocrine tumor	163659	Chemotherapy	RNA synthesis inhibitorGSE96760	hsa	H-STS	Doxorubicin	Neuroendocrine tumor	31703	Chemotherapy	TopoisomeraseGSE96760	hsa	H-STS	Topotecan	Neuroendocrine tumor	60700	Chemotherapy	TopoisomeraseGSE87879	hsa	H1299	Palbociclib	LUAD	5330286	Targeted therapy	CDK4/6	KinaseGSE100169	hsa	H1417	T3775440	LUAD	135397709	Targeted therapy	LSD1	EpigeneticGSE57422	hsa	H1975	Erlotinib	LUAD	176870	Targeted therapy	EGFR	TKIGSE57422	hsa	H1975	Quinacrine	LUAD	237	OthersGSE110397	hsa	H2030	Palbociclib	LUAD	5330286	Targeted therapy	CDK4/6	KinaseGSE110397	hsa	H2030	Trametinib	LUAD	11707110	Targeted therapy	MEK	KinaseGSE110397	hsa	H2030	Palbociclib+Trametinib	LUAD		CombinationGSE89127	hsa	H3122	Crizotinib	LUAD	11626560	Targeted therapy	ALK	TKIGSE89127	hsa	H3122	THZ1	LUAD	73602827	Targeted therapy	CDK7	KinaseGSE89127	hsa	H3122	Crizotinib+THZ1	LUAD		CombinationGSE110397	hsa	H460	Palbociclib	LUAD	5330286	Targeted therapy	CDK4/6	KinaseGSE110397	hsa	H460	Trametinib	LUAD	11707110	Targeted therapy	MEK	KinaseGSE110397	hsa	H460	Palbociclib+Trametinib	LUAD		CombinationGSE100169	hsa	H510	T3775440	LUAD	135397709	Targeted therapy	LSD1	EpigeneticGSE100169	hsa	H526	T3775440	LUAD	135397709	Targeted therapy	LSD1	EpigeneticGSE43510	hsa	HBL-1	R406	DLBCL	11984591	Targeted therapy	SYK	TKIGSE79688	hsa	HCC4006.R	Gefitinib	LUAD	123631	Targeted therapy	EGFR	TKIGSE38310	hsa	HCC827	Erlotinib	LUAD	176870	Targeted therapy	EGFR	TKIGSE51212	hsa	HCC827	Erlotinib	LUAD	176870	Targeted therapy	EGFR	TKIGSE51212	hsa	HCC827	AZD6244	LUAD	10127622	Targeted therapy	MEK1/2	KinaseGSE51212	hsa	HCC827	BEZ235	LUAD	11977753	Targeted therapy	PI3K/mTOR	KinaseGSE79688	hsa	HCC827.R	Gefitinib	LUAD	123631	Targeted therapy	EGFR	TKIGSE95513	hsa	HCT116	JQ1	COAD_READ	46907787	Targeted therapy	BET	EpigeneticGSE96035	hsa	HCT116	Entinostat	COAD_READ	4261	Targeted therapy	HDAC	EpigeneticGSE95513	hsa	HCT116	Bortezomib	COAD_READ	387447	Targeted therapy	proteasome	OthersGSE95513	hsa	HCT116	JQ1+Bortezomib	COAD_READ		CombinationGSE31058	hsa	HD-MyZ	Perifosine	Hodgkin lymphoma	148177	Targeted therapy	AKT	KinaseGSE31058	hsa	HD-MyZ	Sorafenib	Hodgkin lymphoma	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE31058	hsa	HD-MyZ	Perifosine+Sorafenib	Hodgkin lymphoma		CombinationGSE31057	hsa	HDLM2	Perifosine	Hodgkin lymphoma	148177	Targeted therapy	AKT	KinaseGSE31057	hsa	HDLM2	Sorafenib	Hodgkin lymphoma	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE31057	hsa	HDLM2	Perifosine+Sorafenib	Hodgkin lymphoma		CombinationGSE96792	hsa	Hep3B	Sorafenib	LIHC	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE105065	hsa	HepG2	SGI-110	LIHC	135564655	Targeted therapy	DNMT	EpigeneticGSE96793	hsa	HepG2	Sorafenib	LIHC	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE57130	hsa	Het	MS275	ESCA	4261	Targeted therapy	HDAC1/3	EpigeneticGSE57130	hsa	Het	Azacitidine+MS275	ESCA		CombinationGSE57130	hsa	Het	Azacitidine	ESCA	9444	ChemotherapyGSE73024	hsa	HSC-39	CH5183284	STAD	66555680	Targeted therapy	FGFR	TKIGSE38823	hsa	HSC3	Decitabine	Oral cancer	451668	ChemotherapyGSE74842	hsa	HSC57	PD0325901	STAD	9826528	Targeted therapy	MEK	KinaseGSE31019	hsa	HT1080	U0126	Fibrosarcoma	60101647	Targeted therapy	MEK1/2	KinaseGSE59368	hsa	HT1080	Quercetin	Fibrosarcoma	5280343	Others	antioxidantGSE31019	hsa	HT1080	IFN	Fibrosarcoma		OthersGSE31019	hsa	HT1080	IFN+U0126	Fibrosarcoma		CombinationGSE59368	hsa	HT1080	MMS	Fibrosarcoma	4156	Chemotherapy	altering and damaging DNAGSE59368	hsa	HT1080	Etoposide	Fibrosarcoma	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE68453	hsa	HT144	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	HT144	Mastinib	SKCM	10074640	Targeted therapy	cKit/PDGFR/Lck/FAK/FGFR3	TKIGSE68453	hsa	HT144	Lapatinib	SKCM	208908	Targeted therapy	HER2/neu & EGFR	TKIGSE68453	hsa	HT144	PLX4720+Lapatinib	SKCM		CombinationGSE68453	hsa	HT144	PLX4720+Mastinib	SKCM		CombinationGSE50791	hsa	HT29	PLX4720	COAD_READ	24180719	Targeted therapy	BRAF	OncogeneGSE75620	hsa	Huh7	Sorafenib	LIHC	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE96794	hsa	Huh7	Sorafenib	LIHC	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE104664	hsa	HUVEC	h2o2	normal(Umbilical Cord)	784	OthersGSE78234	hsa	Jurkat	Panobinostat	T lymphoblastoid	6918837	Targeted therapy	HDAC	EpigeneticGSE73024	hsa	KATO-III	CH5183284	STAD	66555680	Targeted therapy	FGFR	TKIGSE73024	hsa	KMS-11	CH5183284	Myeloma	66555680	Targeted therapy	FGFR	TKIGSE78234	hsa	KOPN8	Panobinostat	DLBCL	6918837	Targeted therapy	HDAC	EpigeneticGSE40512	hsa	KOPTK1	Palbociclib	T Lymphocyte	5330286	Targeted therapy	CDK4/6	KinaseGSE97985	hsa	L363	MS275	Myeloma	4261	Targeted therapy	HDAC1/3	EpigeneticGSE97985	hsa	L363	Rapamycin	Myeloma	5284616	Targeted therapy	mTOR	KinaseGSE97985	hsa	L363	Rapamycin+MS275	Myeloma		CombinationGSE31059	hsa	L540	Perifosine	Hodgkin lymphoma	148177	Targeted therapy	AKT	KinaseGSE31059	hsa	L540	Sorafenib	Hodgkin lymphoma	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE31059	hsa	L540	Perifosine+Sorafenib	Hodgkin lymphoma		CombinationGSE86597	hsa	LS180	KR12	COAD_READ		Targeted therapy	KRAS	OncogeneGSE28645	hsa	LY2	Tamoxifen	BRCA	2733525	Hormon therapy	ERGSE43510	hsa	LY7	R406	DLBCL	11984591	Targeted therapy	SYK	TKIGSE99060	hsa	M361	abemaciclib	SARC	46220502	Targeted therapy	CDK4/6	KinaseGSE99060	hsa	M453	abemaciclib	BRCA	46220502	Targeted therapy	CDK4/6	KinaseGSE50516	hsa	Mammospheres	Shp2i	BRCA		Single gene perturbation	SHP2GSE50516	hsa	Mammospheres	Shp2ko	BRCA		Single gene perturbation	SHP2GSE99060	hsa	MCF	abemaciclib	BRCA	46220502	Targeted therapy	CDK4/6	KinaseGSE33366	hsa	MCF7	Letrozole	BRCA	3902	Targeted therapy	Aromatase	OthersGSE33366	hsa	MCF7	BMS-754807	BRCA	24785538	Targeted therapy	IGF-IR/InsR	TKIGSE62477	hsa	MCF7	MELK-T1	BRCA	132472238	Targeted therapy	MELK	KinaseGSE33366	hsa	MCF7	Tamoxifen	BRCA	2733526	Hormon therapy	ERGSE33366	hsa	MCF7	Letrozole+BMS-754807	BRCA		CombinationGSE33366	hsa	MCF7	Tamoxifen+BMS-754807	BRCA		CombinationGSE52434	hsa	MCL	AFN700	Lymphoma		Targeted therapy	IKKB	OthersGSE53309	hsa	MCL	mTOR	Lymphoma	59239114	Targeted therapy	mTOR	KinaseGSE53309	hsa	MCL	panPI3K	Lymphoma		Targeted therapy	pan-PI3K	KinaseGSE53309	hsa	MCL	PI3K+mTOR	Lymphoma		CombinationGSE84863	hsa	MDA-MB231	MMS	BRCA	4156	Chemotherapy	altering and damaging DNAGSE84863	hsa	MDA-MB231	Etoposide	BRCA	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE84863	hsa	MDA-MB231	Paclitaxel	BRCA	36314	Chemotherapy	MicrotubuleGSE84863	hsa	MDA-MB231	Doxorubicin	BRCA	31703	Chemotherapy	TopoisomeraseGSE41816	hsa	MDA231	AZD6244	BRCA	10127622	Targeted therapy	MEK1/2	KinaseGSE41816	hsa	MDA231	siDUSP4	BRCA		Single gene perturbation	DUSP4GSE99536	hsa	MDAMB231	Sorafenib	BRCA	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE99536	hsa	MDAMB231	MMS+Sorafenib	BRCA		CombinationGSE99536	hsa	MDAMB231	MMS	BRCA	4156	Chemotherapy	altering and damaging DNAGSE33624	hsa	MelJuSo	Etoposide	SKCM	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE33624	hsa	MelJuSo	Doxorubicin	SKCM	31703	Chemotherapy	TopoisomeraseGSE73024	hsa	MFE-280	CH5183284	UCEC	66555680	Targeted therapy	FGFR	TKIGSE73024	hsa	MFE-296	CH5183284	UCEC	66555680	Targeted therapy	FGFR	TKIGSE110397	hsa	Mia	Palbociclib	PAAD	5330286	Targeted therapy	CDK4/6	KinaseGSE110397	hsa	Mia	Trametinib	PAAD	11707110	Targeted therapy	MEK	KinaseGSE110397	hsa	Mia	Palbociclib+Trametinib	PAAD		CombinationGSE84205	hsa	MPNST	Vorinostat	nerve sheath tumor	5311	Targeted therapy	HDACI/II/IV	EpigeneticGSE84205	hsa	MPNST	INK128	nerve sheath tumor		Targeted therapy	mTOR	KinaseGSE84205	hsa	MPNST	INK128+Vorinostat	nerve sheath tumor		CombinationGSE89127	hsa	N87	THZ1	STAD	73602827	Targeted therapy	CDK7	KinaseGSE89127	hsa	N87	Lapatinib	STAD	208908	Targeted therapy	HER2/neu & EGFR	TKIGSE89127	hsa	N87	Lapatinib+THZ1	STAD		CombinationGSE107354	hsa	NB39nu	Alectinib	neuroblastoma	49806720	Targeted therapy	ALK	TKIGSE107354	hsa	NB39nu	Crizotinib	neuroblastoma	11626560	Targeted therapy	ALK	TKIGSE107354	hsa	NB39nu.R	Alectinib	neuroblastoma	49806720	Targeted therapy	ALK	TKIGSE107354	hsa	NB39nu.R	Crizotinib	neuroblastoma	11626560	Targeted therapy	ALK	TKIGSE73024	hsa	NCI-716	CH5183284	COAD	66555680	Targeted therapy	FGFR	TKIGSE73024	hsa	NCI-H1581	AZD4547	LUAD	51039095	Targeted therapy	FGFR	TKIGSE73024	hsa	NCI-H1581	CH5183284	LUAD	66555680	Targeted therapy	FGFR	TKIGSE73024	hsa	NCI-H1581	CH4987655	LUAD	11548630	Targeted therapy	MEK	KinaseGSE73024	hsa	NCI-H1581	CH5132799	LUAD	49784945	Targeted therapy	PI3K	KinaseGSE73024	hsa	NCI-H520	CH5183284	LUAD	66555680	Targeted therapy	FGFR	TKIGSE45626	hsa	NCI-H526	R1507	SCLC	5376617	Targeted therapy	IGF-1R	TKIGSE45626	hsa	NCI-H526	Radiation	SCLC	62767	RadiotherapyGSE45626	hsa	NCI-H526	CDDP	SCLC	56842080	ChemotherapyGSE73024	hsa	NCI-N87	CH5183284	LUAD	66555680	Targeted therapy	FGFR	TKIGSE38823	hsa	OC3	Decitabine	Oral cancer	451668	ChemotherapyGSE54979	hsa	OCCC	GSK126	BRCA	68210102	Targeted therapy	EZH2	EpigeneticGSE54979	hsa	OCCC	ARID1A	BRCA		OthersGSE51068	hsa	OCI-LY3	Monastrol	DLBCL	2987927	Targeted therapy	Eg5	OthersGSE51068	hsa	OCI-LY3	Trichostatin A	DLBCL	444732	Targeted therapy	HDACI/II	EpigeneticGSE51068	hsa	OCI-LY3	Geldanamycin	DLBCL	5288382	Targeted therapy	Hsp90	OthersGSE51068	hsa	OCI-LY3	Rapamycin	DLBCL	5284616	Targeted therapy	mTOR	KinaseGSE51068	hsa	OCI-LY3	H-7 Dihydrochloride	DLBCL	73332	Targeted therapy	Protien kinase inhibitor	KinaseGSE51068	hsa	OCI-LY3	Methotrexate	DLBCL	126941	Others	a Folate Analog MetabolicGSE51068	hsa	OCI-LY3	Blebbistatin	DLBCL	3476986	Others	ATPaseGSE51068	hsa	OCI-LY3	Vincristine	DLBCL	5978	Chemotherapy	binds irreversibly to microtubules and spindle proteins in S phase of the cell cycleGSE51068	hsa	OCI-LY3	Cycloheximide	DLBCL	6197	Chemotherapy	inhibit both the synthesis of proteins and macromoleculesGSE51068	hsa	OCI-LY3	Aclacinomycin A	DLBCL	451415	Chemotherapy	inhibiting DNA replication and repair and RNA and protein synthesisGSE51068	hsa	OCI-LY3	Mitomycin C	DLBCL	5746	Chemotherapy	inhibition of DNA synthesiGSE51068	hsa	OCI-LY3	Etoposide	DLBCL	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE51068	hsa	OCI-LY3	Camptothecin	DLBCL	24360	Chemotherapy	inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE IGSE51068	hsa	OCI-LY3	Doxorubicin hydrochloride	DLBCL	443939	Chemotherapy	prevents DNA replicationGSE57130	hsa	OE21	MS275	ESCA	4261	Targeted therapy	HDAC1/3	EpigeneticGSE57130	hsa	OE21	Azacitidine+MS275	ESCA		CombinationGSE57130	hsa	OE21	Azacitidine	ESCA	9444	ChemotherapyGSE57130	hsa	OE33	MS275	ESCA	4261	Targeted therapy	HDAC1/3	EpigeneticGSE57130	hsa	OE33	Azacitidine+MS275	ESCA		CombinationGSE57130	hsa	OE33	Azacitidine	ESCA	9444	ChemotherapyGSE84862	hsa	OPM2	VS5584	Myeloma		Targeted therapy	PI3K/mTOR	KinaseGSE110397	hsa	PANC-1	Palbociclib	PAAD	5330286	Targeted therapy	CDK4/6	KinaseGSE110397	hsa	PANC-1	Trametinib	PAAD	11707110	Targeted therapy	MEK	KinaseGSE110397	hsa	PANC-1	Palbociclib+Trametinib	PAAD		CombinationGSE87886	hsa	PC3-ML	Palbociclib	PRAD	5330286	Targeted therapy	CDK4/6	KinaseGSE89127	hsa	PC9	THZ1	LUAD	73602827	Targeted therapy	CDK7	KinaseGSE34228	hsa	PC9	Gefitinib	LUAD	123631	Targeted therapy	EGFR	TKIGSE89127	hsa	PC9	Erlotinib	LUAD	176870	Targeted therapy	EGFR	TKIGSE34228	hsa	PC9	EGF	LUAD		Hormon therapyGSE34228	hsa	PC9	EGF+Gefitinib	LUAD		CombinationGSE89127	hsa	PC9	Erlotinib+THZ1	LUAD		CombinationGSE34228	hsa	PC9GRM2	Gefitinib	LUAD	123631	Targeted therapy	EGFR	TKIGSE34228	hsa	PC9GRM2	EGF	LUAD		Hormon therapyGSE34228	hsa	PC9GRM2	EGF+Gefitinib	LUAD		CombinationGSE99062	hsa	PDX	abemaciclib	BRCA	46220502	Targeted therapy	CDK4/6	KinaseGSE112371	hsa	PEO1.R.PDX	Selumetinib	OV	10127622	Targeted therapy	MEK	KinaseGSE112371	hsa	PEO1.R.PDX	Saracatinib	OV	10302451	Targeted therapy	Src	TKIGSE112371	hsa	PEO1.R.PDX	Selumetinib+Saracatinib	OV		CombinationGSE49284	hsa	Raji	EPZ6438	Burkitt's lymphoma	66558664	Targeted therapy	EZH2	EpigeneticGSE48399	hsa	Raji	NaB	Burkitt's lymphoma		Targeted therapy	HDAC	EpigeneticGSE48399	hsa	Raji	VP16+NaB	Burkitt's lymphoma		CombinationGSE48399	hsa	Raji	VP16	Burkitt's lymphoma		ChemotherapyGSE78234	hsa	REH	Panobinostat	B lymphoma	6918837	Targeted therapy	HDAC	EpigeneticGSE95513	hsa	RKO	JQ1	COAD_READ	46907787	Targeted therapy	BET	EpigeneticGSE108265	hsa	RKO	NCD38	COAD_READ		Targeted therapy	LDS1	EpigeneticGSE108265	hsa	RKO	P4	COAD_READ	123286	Targeted therapy	LDS1	EpigeneticGSE108265	hsa	RKO	PIPP	COAD_READ	59003730	Targeted therapy	LDS1	EpigeneticGSE73024	hsa	RT-4	CH5183284	BLCA	66555680	Targeted therapy	FGFR	TKIGSE89127	hsa	RT112	THZ1	BLCA	73602827	Targeted therapy	CDK7	KinaseGSE89127	hsa	RT112	BGJ398	BLCA	53235510	Targeted therapy	FGFRs	TKIGSE89127	hsa	RT112	BGJ398+THZ1	BLCA		CombinationGSE38823	hsa	SAS	Decitabine	Oral cancer	451668	ChemotherapyGSE38823	hsa	SCC-15	Decitabine	Oral cancer	451668	ChemotherapyGSE55830	hsa	SCLC	ABT888	LUAD	11960529	Targeted therapy	PARPs	OthersGSE55830	hsa	SCLC	Radiation	LUAD	62767	RadiotherapyGSE55830	hsa	SCLC	Cisplatin+ABT888	LUAD		CombinationGSE55830	hsa	SCLC	Cisplatin	LUAD	5702198	ChemotherapyGSE78234	hsa	SEM	Panobinostat	B lymphoma	6918837	Targeted therapy	HDAC	EpigeneticGSE74842	hsa	SH10TC	PD0325901	STAD	9826528	Targeted therapy	MEK	KinaseGSE75620	hsa	shRb	Sorafenib	LIHC	216239	Targeted therapy	VEGFR, PDGFR, CRAF	TKIGSE68453	hsa	SKMEL2	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	SKMEL24	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	SKMEL24	Mastinib	SKCM	10074640	Targeted therapy	cKit/PDGFR/Lck/FAK/FGFR3	TKIGSE68453	hsa	SKMEL24	Lapatinib	SKCM	208908	Targeted therapy	HER2/neu & EGFR	TKIGSE68453	hsa	SKMEL24	PLX4720+Lapatinib	SKCM		CombinationGSE68453	hsa	SKMEL24	PLX4720+Mastinib	SKCM		CombinationGSE68453	hsa	SKMEL28	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	SKMEL28	Mastinib	SKCM	10074640	Targeted therapy	cKit/PDGFR/Lck/FAK/FGFR3	TKIGSE68453	hsa	SKMEL28	Lapatinib	SKCM	208908	Targeted therapy	HER2/neu & EGFR	TKIGSE68453	hsa	SKMEL28	PLX4720+Lapatinib	SKCM		CombinationGSE68453	hsa	SKMEL28	PLX4720+Mastinib	SKCM		CombinationGSE31019	hsa	SKOV3	IFN	OV		OthersGSE68453	hsa	SLM2	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE73024	hsa	SNU-16	CH5183284	STAD	66555680	Targeted therapy	FGFR	TKIGSE105065	hsa	SNU398	SGI-110	LIHC	135564655	Targeted therapy	DNMT	EpigeneticGSE105065	hsa	SNU475	SGI-110	LIHC	135564655	Targeted therapy	DNMT	EpigeneticGSE74842	hsa	SNU719	PD0325901	STAD	9826528	Targeted therapy	MEK	KinaseGSE45891	hsa	SQ20B	Erlotinib	Others	176870	Targeted therapy	EGFR	TKIGSE41816	hsa	SUM159PT	AZD6244	BRCA	10127622	Targeted therapy	MEK1/2	KinaseGSE41816	hsa	SUM159PT	siDUSP4	BRCA		Single gene perturbation	DUSP4GSE86598	hsa	SW480	KR12	COAD_READ		Targeted therapy	KRAS	OncogeneGSE33624	hsa	SW620	Etoposide	COAD_READ	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE33624	hsa	SW620	Doxorubicin	COAD_READ	31703	Chemotherapy	TopoisomeraseGSE38310	hsa	T15-2	Erlotinib	LUAD	176870	Targeted therapy	EGFR	TKIGSE102483	hsa	TF1a	Rapamycin	erythroleukemia	5284616	Targeted therapy	mTOR	KinaseGSE102483	hsa	TF1a	TGFB1	erythroleukemia		Others	TGFB1GSE102483	hsa	TF1a	TGFB1+Rapamycin	erythroleukemia		CombinationGSE102483	hsa	TF1a	Etoposide	erythroleukemia	36462	Chemotherapy	TOP2B,TOP2AGSE74842	hsa	TMK1	PD0325901	STAD	9826528	Targeted therapy	MEK	KinaseGSE39691	hsa	TNBC	Sirolimus	BRCA	5284616	Targeted therapy	mTOR	KinaseGSE49414	hsa	TPC1	RPI1	THCA	1749978	Targeted therapy	cMET	TKIGSE43510	hsa	U2932	R406	DLBCL	11984591	Targeted therapy	SYK	TKIGSE84863	hsa	U2OS	MMS	osteosarcoma	4156	Chemotherapy	altering and damaging DNAGSE84863	hsa	U2OS	Etoposide	osteosarcoma	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE84863	hsa	U2OS	Paclitaxel	osteosarcoma	36314	Chemotherapy	MicrotubuleGSE84863	hsa	U2OS	Doxorubicin	osteosarcoma	31703	Chemotherapy	TopoisomeraseGSE66660	hsa	U937.EVI1	Etoposide	lymphoma	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE66660	hsa	U937.vec	Etoposide	lymphoma	36462	Chemotherapy	inhibits DNA synthesis by forming a complex with topoisomerase II and DNAGSE73024	hsa	UM-UC-14	CH5183284	BLCA	66555680	Targeted therapy	FGFR	TKIGSE68453	hsa	VMM12	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	VMM15	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	VMM17	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	VMM18	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	VMM39	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE68453	hsa	VMM5A	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE59342	hsa	WM35	Crizotinib	SKCM	11626560	Targeted therapy	ALK	TKIGSE59341	hsa	WM35	Lactimidomycin	SKCM	11669726	Chemotherapy	inhibitor of protein translation in ribosomesGSE59342	hsa	WM35	Ciclopirox	SKCM	2749	Chemotherapy	Protein SynthesisGSE59341	hsa	WM35	Trifluridine	SKCM	6256	ChemotherapyGSE58721	hsa	WM9	PLX4720	SKCM	24180719	Targeted therapy	BRAF	OncogeneGSE107912	hsa	EVSAT.siCtrl	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	EVSAT.TNFR1	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	MDA	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	EVSAT	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	MDA.IRF1	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	MDA.none	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	MDA.RELA	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	MDA.siCtrl	BV6	BRCA		Targeted therapy	IAPGSE107912	hsa	MDA.TNFR1	BV6	BRCA		Targeted therapy	IAPGSE129071	hsa	MHCC97L	Oxaliplatin	HCC		ChemotherapyGSE33827	hsa	MDAMB231	SM164	BRCA		Targeted therapyGSE48399	hsa	Raji	NaB	B lymphoma		ChemotherapyGSE48399	hsa	Raji	VP16	B lymphoma		ChemotherapyGSE62533	hsa	CLL	BV6	CLL		Targeted therapy	IAPGSE98691	hsa	MDA-MB231	SM83	BRCA		Targeted therapy	IAP